Mark Ridgway
Global Guide 2024
Band 3 : Intellectual Property: Patent Litigation
Email address
[email protected]Contact number
+44 20 3088 3720Share profile
Band 3
About
Provided by Mark Ridgway
Practice Areas
Mark is an intellectual property litigator with over 20 years’ experience, advising on a wide range of cross-border, contentious matters.
Mark has particular expertise in multi-jurisdictional patent disputes, as well as in patent licensing and trade secrets disputes, advising clients primarily from the life sciences, technology and financial services sectors.
Mark has a technical background (BEng (Hons) in Electronic Engineering), allowing him to take on the most complex cases whilst delivering strategic and commercial advice to clients. Mark is ranked as a Leading Individual by Legal 500 (Intellectual Property: Patents), as well as by other major directories. In the area of trade secrets, Mark is a member of the AIPPI Standing Committee on Trade Secrets and chairs the trade secrets sub-committee of a major UK industry association.
Chambers Review
Global
Mark Ridgway represents clients in a range of complex litigation covering FRAND and standard-essential patents, infringement actions and trade secret cases. He acts for many market-leading technology and life sciences companies.
Strengths
Provided by Chambers
"Mark Ridgway is extremely sharp, with fantastic litigation instincts. He predicts how the case would go. A strategic thinker and pragmatic in his advice."
"Mark is highly rated here. He has a particular niche in the pharmaceutical market, and is very personable and easy to work with."
"Mark is so dynamic. Clients love him. His strength goes across different areas such as pharma and tech."
"Mark Ridgway is extremely sharp, with fantastic litigation instincts. He predicts how the case would go. A strategic thinker and pragmatic in his advice."
"Mark is highly rated here. He has a particular niche in the pharmaceutical market, and is very personable and easy to work with."
"Mark is so dynamic. Clients love him. His strength goes across different areas such as pharma and tech."